RE: Presentation11 Jan 2024 11:54
The shareprice is holding up well today as we enter the final day of the JPM chase 42nd annual healthcare conference,the largest of its type in the world and the place where deals are made for the Bio sector.
All the industry heavy hitters are in attendance and we can only hope that the ground work has been done last year to attract a large partner. We have a couple of serious partners in the data room we have been told so I hope an agreement can be made for a suitable partner to progress one or more of our products forward. It has been mentioned in the past that one of these potential partners is actively encouraging Poolbeg to explore the oncology angle as a CRS blocker for our lead flagship product Polb 001.
We are sure to be hitting the ground running in 2024 and I feel news on some front is not far away.